The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Levin O.S.
Russian Medical Academy of Continuous Professional Education
Bogolepova A.N.
Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency
Poststroke motor and cognitive impairments: clinical features and current approaches to rehabilitation
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(11): 99‑107
Views: 50336
Downloaded: 1434
To cite this article:
Levin OS, Bogolepova AN. Poststroke motor and cognitive impairments: clinical features and current approaches to rehabilitation. S.S. Korsakov Journal of Neurology and Psychiatry.
2020;120(11):99‑107. (In Russ.)
https://doi.org/10.17116/jnevro202012011199
Stroke is one of the most common neurological diseases with high morbidity, disability and mortality, which is an urgent medical and social problem. Clinically, stroke, depending on its nature and location, causes a wide range of neurological disorders, including movement disorders, as well as a variety of cognitive and neuropsychiatric disorders. There is an emerging need for new approaches to manage patients with cerebrovascular diseases during the pandemic of COVID-19. Rehabilitation measures for the correction of motor and cognitive impairments are very diverse. The use of drugs stimulating the production of neurotrophic factors is considered as a promising direction of pharmacotherapy. Cerebrolysin promotes significant regression of motor and cognitive impairments in the acute and recovery period of ischemic stroke. Based on the data of clinical studies, Cerebrolysin is included in the guidelines for the rehabilitation of patients with stroke in Canada and Germany.
Keywords:
Authors:
Levin O.S.
Russian Medical Academy of Continuous Professional Education
Bogolepova A.N.
Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency
Received:
16.11.2020
Accepted:
22.11.2020
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.